Ultrasound News and Research

RSS

Ultrasound is a procedure in which high-energy sound waves are bounced off internal tissues or organs and make echoes. The echo patterns are shown on the screen of an ultrasound machine, forming a picture of body tissues called a sonogram. Also called ultrasonography.

Results from the BLOSSOM trial announced by Arena Pharmaceuticals

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) reported today positive, highly significant top-line results from the BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) trial.

18 Sep 2009

Mayo Clinic Women's HealthSource discusses myths and facts about ovarian cancer

But not all the news about ovarian cancer is grim. Incidence is declining. Doctors are learning more about early symptoms and more effective treatments. The September issue of Mayo Clinic Women's HealthSource looks at myths and facts about ovarian cancer.

17 Sep 2009

Educational events for physicians who diagnose and treat prostate cancer

iCAD, Inc., an industry-leading provider of advanced image analysis and workflow solutions for the early identification of cancer, today announces a series of educational events designed for radiologists, urologists, oncologists, radiation oncologists, surgeons, technologists and other referring physicians who diagnose and treat patients with prostate cancer.

17 Sep 2009

Celsion's DIGNITY clinical trial aired on Good Morning America

Celsion Corporation announced today the Company’s DIGNITY clinical trial evaluating the use of ThermoDox in combination with hyperthermia for the treatment of Recurrent Chest Wall (RCW) Breast Cancer was aired during commercial breaks on Good Morning America and CBS Sunday Morning this past weekend.

16 Sep 2009

Next Generation Advanced Image Processing for Toshiba Infinix-i product line

Improving the ability to provide premium patient care during interventional procedures, Toshiba America Medical Systems, Inc. is expanding the availability of Next Generation Advanced Image Processing (AIP) to more systems in the Toshiba InfinixTM-i product line.

16 Sep 2009

SSO2 administration reduces heart muscle damage

Supersaturated oxygen (SSO2) administered during catheter-based treatments for heart attack can significantly reduce heart muscle damage, according to a new study reported in Circulation: Cardiovascular Interventions, a journal of the American Heart Association.

16 Sep 2009

Cardiac MRI exams gain prominence in the medical imaging market

Developments in imaging technology and software continue to help cardiac MRI exams gain prominence in the medical imaging market by meeting the demand for faster scan times and the ability to view areas of the body that were previously deemed impossible to image, according to "Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound" by healthcare market research firm Kalorama Information.

16 Sep 2009

Exercise is effective for treating chronic shoulder pain

Supervised exercises are more effective than shockwave treatment to relieve chronic shoulder pain, finds a study published on bmj.com today.

16 Sep 2009

Significant uptake of medical imaging equipment in Ghana

Ghana's healthcare industry is experiencing growth across a range of sectors. However, the drive towards improved diagnostic capability has led to high demand for medical imaging devices.

15 Sep 2009

SonoSite to showcase the NanoMaxx ultrasound tool for vascular access applications at AVA

SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried and point-of-care ultrasound, announced today new patient safety technology, mobile power solutions and image quality advances for vascular access applications. The company will be showcasing the new products and capabilities at the annual scientific meeting of the Association for Vascular Access (AVA) being held in Las Vegas September 14th - 18th, 2009.

15 Sep 2009

Development of noninvasive imaging and treatment of the heart chronicled in a new article

Fifty-one years ago the average American home cost $30,000, Elvis Presley wooed listeners with Hard Headed Woman, and the hula hoop was introduced. That same year, 1958, a team comprised of a groundbreaking engineer -- Dean Franklin -- in concert with two exceptional physicians -- Drs. Robert Rushmer and Robert Van Citters - was laying the foundation for what would eventually become a radical new approach to health care: the noninvasive imaging and treatment of the heart.

15 Sep 2009

ALF, Celsion partner to educate physicians about primary liver cancer treatments

Celsion Corporation (NASDAQ:CLSN) and the American Liver Foundation (ALF) announced today that they have formed a partnership to provide education to physicians and liver patients about the treatment options for hepatocellular carcinoma (commonly referred to as primary liver cancer) and Celsion’s on-going ThermoDox Phase III global HEAT clinical study.

14 Sep 2009

FDA to consider an additional labelling claim for Noveko's masks and respirators

Noveko International Inc. ("the Company") is pleased to announce that further to its request, the Food and Drugs Administration (the "FDA") accepted to meet with the Company, to consider an additional labelling claim for its Noveko(TM) masks and respirators.

14 Sep 2009

Protox' Phase 2 study of PRX302 for treating BPH provides positive results

Protox Therapeutics Inc. (TSX: PRX), a leader in the development of receptor targeted fusion proteins, today announced positive 12 month data from its open-label Phase 2 study of PRX302 in males with moderate to severe benign prostatic hyperplasia (BPH). The study results indicate that those patients who received an optimal dose of PRX302 continued to demonstrate significant symptomatic relief at 12 months following a single treatment.

10 Sep 2009

Patient enrollment for Phase 2b study of PRX302 completed by Protox Therapeutics

Protox Therapeutics Inc. (TSX: PRX), a leader in the development of receptor targeted fusion proteins, today announced that it has completed patient enrollment in its multi-centre, double-blinded, placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in males with moderate to severe benign prostatic hyperplasia (BPH), a common and bothersome urological condition that affects more than 50 million men worldwide.

8 Sep 2009

Noveko International to raise funds for pursuing its global growth objectives

Noveko International Inc. ("the Company") is pleased to announce that it has entered into an agreement with Desjardins Securities Inc. as lead Agent on behalf of a syndicate (collectively "the Agents") to raise approximately C$10 million of Units (the "Units") by way of a best efforts private placement (the "Offering"). Each Unit will consist of one Class A Share of the Company and one-half of one Class A Share purchase warrant. The Units will be priced in the context of the market.

5 Sep 2009

Mindray DS USA announces the recent appointment of its Vice President

Mindray DS USA, a Mindray Global Company, announces the recent appointment of Michael Thompson as vice president of ultrasound sales for the U.S. Thompson brings more than 20 years of medical sales, sales force management and business development to the position.

From Mindray 4 Sep 2009

Medipattern raises funds for general working capital purposes

The Medipattern Corporation ("Medipattern" or the "Company") (TSX VENTURE:MKI), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that it has closed a non-brokered private placement (the "Offering") of 2,500,000 common shares in the capital stock of the Company at $0.20 per common share, for gross proceeds of $500,000.00 to the Company.

3 Sep 2009

IGRT offers improved treatment results for obese prostate cancer patients

Moderately to severely obese prostate cancer patients may have improved treatment outcomes when treated with image-guided radiation therapy (IGRT) over traditional external beam radiation therapy (EBRT) because IGRT corrects for prostate shifts, which, if not planned for, can lead to incorrect doses of radiation to the disease site, according to a study in the September 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).

3 Sep 2009

New findings on molecular imaging and prostate cancer

A new study published in the September issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET)/computer tomography (CT) scans with the imaging agent choline could detect recurring prostate cancer sooner than conventional imaging technologies in some patients who have had their prostates surgically removed.

2 Sep 2009